i-gel® from Intersurgical: clinical evidence listing

Cook TM, Kelly FE. Anaesthesia. 2016 Apr;71(4):466-7

Based on the findings of the DAS 2015 guidelines, the authors argue that evidence suggests 2nd generation supraglottic airway devices perform better than 1st generation equivalents, and that 2nd gen should be used for airway rescue and routine airway management.

Link to abstract

Abukawa Y, Hiroki K, Iwakiri H, Fukuda T, Ozaki M. J Anesth. 2016;30(2):199-204

130 patients aged 7 months to 13 years monitored under general anaesthesia, with size selection based on patient's body weight. Average insertion length grew longer with increasing height and weight. Authors conclude a line could be drawn on sizes 1.5 and 2 only.

Link to abstract

Guerrier G, Boutboul D, Rondet S, Hallal D, Levy J, Sjogren L, Legeais JM, Nicolau R, Mehanna C, Bourges JL, Samama CM. Cornea 2016;35(1):37-40

Study to assess the safety of the i-gel in keratoplasty performed under general anaesthesia, compared to tracheal tube intubation. No surgical complications reported in either group.

Link to abstract

El-Boghdadly K, Bailer R, Wiles M. Anaesthesia 2016;71(6):706-17

Review into prevalence of sore throat after use of supraglottic airway devices against tracheal intubation in general anaesthesia. Authors suggest that, in adults, i-gel results in a lower incidence of post-operative sore throat.

Link to abstract

Choi JJ, Kim JY, Lee D, Chang YJ, Cho NR, Kwak HJ. BMC Anesthesiol. 2016 Mar 22;16:20

40 patients were split into equal gender groups prior to insertion. The EC50 of propofol in men was approximately 40% higher than in women. Gender should be considered when determining optimal dose of propofol, according to the authors.

Link to abstract